GO:0003682 chromatin binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003682 chromatin binding is a molecular function describing the binding to chromatin, the DNA-protein-RNA fiber network of eukaryotic chromosomes during interphase.
• Chromatin binding is mediated by conserved structural domains that recognize DNA, histone modifications, or nucleosome surfaces, enabling dynamic regulation of genome accessibility.
• Key chromatin-binding proteins include CTCF, UHRF1, PCNA-associated factor CAF-1, condensin II subunits, and TICRR/TRESLIN, each with distinct cell-cycle and architectural roles.
• Dysregulated chromatin binding contributes to cancer, developmental disorders, and immune pathologies such as NET formation.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of chromatin-binding domains in cells and organisms.
• EDITGENE provides end-to-end CRISPR services and bioinformatics to accelerate chromatin binding research.
Description
Chromatin binding (GO:0003682) is a fundamental molecular function that governs how proteins interact with the eukaryotic genome. The term refers to the binding to chromatin, the network of fibers composed of DNA, protein, and sometimes RNA, that make up chromosomes during interphase. This function is critical for organizing the genome, regulating gene expression, and maintaining genomic stability. Researchers study chromatin binding to understand processes ranging from transcription factor targeting to chromosome segregation and epigenetic inheritance. The specificity and dynamics of chromatin binding are determined by protein domains that recognize DNA sequences, histone post-translational modifications, or structural features of nucleosomes. Disruption of these interactions is linked to diseases including cancer, developmental syndromes, and autoinflammatory conditions. Therefore, precise experimental models are needed to dissect the molecular mechanisms and disease relevance of chromatin-binding proteins.
chromatin binding At A Glance
| GO ID | GO:0003682 |
|---|---|
| GO term | chromatin binding |
| Ontology | molecular_function |
| Synonym | lamin/chromatin binding; microtubule/chromatin interaction; nuclear membrane vesicle binding to chromatin |
| Major function | Binding to chromatin fibers, enabling protein recruitment to specific genomic regions and regulation of chromatin structure |
| Related processes | Transcription regulation, DNA replication, chromosome segregation, epigenetic inheritance |
| Example proteins | CTCF, UHRF1, CAF-1, condensin II, TICRR/TRESLIN, EZHIP |
| Disease relevance | Cancer, developmental disorders, neutrophil extracellular trap formation |
What Is GO:0003682?
According to the Gene Ontology, chromatin binding (GO:0003682) is the binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. This molecular function encompasses interactions with any component of chromatin, including DNA, histones, and non-histone proteins, and is essential for diverse nuclear processes.
Why Is chromatin binding Important in Cell Biology?
Chromatin binding is central to virtually all DNA-templated processes, including transcription, replication, repair, and chromosome segregation. Proteins that bind chromatin must do so with high specificity and dynamic regulation to ensure proper gene expression and genome integrity. Dysregulation of chromatin binding can lead to aberrant gene silencing or activation, contributing to cancer and developmental diseases. Moreover, chromatin binding is a key mechanism in immune defense, as seen in the formation of neutrophil extracellular traps. Understanding chromatin binding is therefore essential for basic biology and therapeutic development.
• Regulates gene expression by recruiting transcription factors and chromatin remodelers to specific loci.
• Essential for DNA replication and cell cycle progression, as shown for TICRR/TRESLIN and CAF-1.
• Maintains epigenetic memory through proteins like UHRF1 and EZHIP.
• Controls chromosome architecture and segregation via condensin II and CTCF.
• Involved in immune responses, including NET formation by myeloperoxidase.
• Dysregulated in cancers, where altered chromatin binding drives oncogenic transcription programs.
• Target for drug discovery, as chromatin-binding domains are druggable.
• Provides mechanistic insights into developmental disorders caused by mutations in chromatin binders.
• Enables advanced genome engineering by guiding CRISPR components to chromatin.
• Facilitates single-molecule and live-cell imaging studies of genome organization.
What Happens During chromatin binding?
Recognition of chromatin features
In simple terms: Proteins scan the genome for specific chemical marks or DNA sequences.
Chromatin-binding proteins recognize distinct features such as DNA sequence motifs, histone modifications, or nucleosome structure. For example, CTCF binds to specific DNA sequences to organize chromatin loops, while UHRF1 recognizes hemimethylated DNA and histone marks through its conserved linker regions. This recognition is often mediated by modular domains like zinc fingers, bromodomains, or PHD fingers.
Stable association and complex assembly
In simple terms: Once bound, proteins recruit partners to form functional machines.
After initial recognition, chromatin-binding proteins often undergo conformational changes that stabilize their interaction with chromatin. They then recruit additional factors to form complexes. For instance, condensin II activation by M18BP1 involves chromatin binding that triggers ATPase activity and chromosome compaction. Similarly, CAF-1 binds PCNA at replication forks to assemble nucleosomes.
Dynamic regulation and release
In simple terms: Binding is reversible and controlled by cell signals.
Chromatin binding is dynamically regulated by post-translational modifications, cell cycle cues, and effector molecules. TICRR/TRESLIN and MTBP exhibit cell cycle-dependent chromatin binding patterns that coordinate DNA replication initiation. EZHIP restricts noncanonical PRC2 binding to chromatin, influencing H3K27me3 inheritance. Myeloperoxidase modifies chromatin to promote NET formation, illustrating how enzymatic activity can alter chromatin binding.
Functional consequences
In simple terms: Binding leads to changes in gene activity or chromosome structure.
The ultimate outcome of chromatin binding is the regulation of genome function. Transcription factor binding can alter chromatin architecture and gene expression. Chromatin binding by structural proteins like condensin II compacts chromosomes for segregation. These functional consequences are essential for development, differentiation, and stress responses.
Key Genes Involved in GO:0003682 chromatin binding
The following genes encode proteins with validated chromatin-binding activity according to GO:0003682 and the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CTCF | DNA sequence-specific chromatin binding, insulator function, loop organization | Studying 3D genome architecture and transcriptional insulation |
| UHRF1 | Recognizes hemimethylated DNA and histone marks, maintains DNA methylation | Epigenetic inheritance and cancer |
| CAF-1 (CHAF1A/B/C) | Binds PCNA at replication forks, assembles nucleosomes | DNA replication and chromatin assembly |
| EZHIP | Restricts noncanonical PRC2 binding, regulates H3K27me3 | Intergenerational epigenetic inheritance |
| TICRR/TRESLIN | Cell cycle-dependent chromatin binding, replication initiation | DNA replication control |
| MTBP | Chromatin binding partner of TICRR/TRESLIN | Replication origin firing |
| Condensin II subunits (NCAPD3, NCAPH2, etc.) | Chromatin binding for chromosome condensation | Mitosis and genome stability |
| M18BP1 | Activates condensin II via chromatin binding | Chromosome segregation |
| Myeloperoxidase (MPO) | Transforms chromatin into NETs | Innate immunity and autoimmunity |
| Histone H3 | Core chromatin component, target of modifications | Nucleosome dynamics |
| PCNA | Sliding clamp, interacts with CAF-1 | Replication and repair |
| PRC2 subunits (EZH2, SUZ12, EED) | Chromatin binding for H3K27me3 deposition | Polycomb repression |
| Transcription factors (e.g., MYC, p53) | Sequence-specific chromatin binding | Gene regulation and cancer |
| Linker histones (H1) | Bind linker DNA, stabilize higher-order chromatin | Chromatin compaction |
| HP1 proteins | Bind H3K9me3, heterochromatin formation | Gene silencing |
| BRCA1 | Chromatin binding at DNA damage sites | DNA repair |
| Cohesin complex | Chromatin binding for sister chromatid cohesion | Chromosome segregation |
| CTCFL (BORIS) | Paralog of CTCF, chromatin binding | Cancer-testis antigen |
How Is chromatin binding Regulated?
Chromatin binding is regulated at multiple levels. Post-translational modifications of chromatin-binding proteins, such as phosphorylation and ubiquitination, can alter their affinity for chromatin. Cell cycle-dependent kinases control the chromatin binding of replication factors like TICRR/TRESLIN and MTBP. Metabolic enzymes such as myeloperoxidase can modify chromatin itself, thereby changing binding properties. Additionally, noncoding RNAs and RNA-binding proteins can modulate chromatin interactions. The interplay between these regulatory layers ensures that chromatin binding is dynamic and context-specific.
chromatin binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CTCF | Cancer, developmental disorders | Knockout and point mutation in cell lines; organoids |
| EZHIP | Pediatric tumors, epigenetic inheritance defects | Knock-in of mutant EZHIP; overexpression |
| UHRF1 | Cancer, epigenetic disorders | Knockout and tagged knock-in for live imaging |
| MPO | Autoimmune diseases, NET formation | Knockout mice; overexpression in neutrophils |
| Condensin II subunits | Cancer, chromosome instability | Point mutations in ATPase domain; knockout |
Cancer
Altered chromatin binding is a hallmark of cancer. Mutations in chromatin-binding domains of CTCF disrupt insulator function and contribute to oncogenic gene expression. EZHIP-mediated restriction of PRC2 binding affects H3K27me3 inheritance and is implicated in pediatric tumors. Dysregulated condensin II chromatin binding leads to chromosomal instability, a common feature of cancer.
Developmental disorders
Germline mutations in chromatin-binding proteins cause developmental syndromes. For example, mutations in CTCF or its partners result in intellectual disability and growth defects. UHRF1 dysfunction impairs epigenetic inheritance and embryonic development.
Autoinflammatory and immune diseases
Myeloperoxidase-mediated chromatin transformation into neutrophil extracellular traps is involved in autoimmune diseases such as lupus and vasculitis. Targeting chromatin binding in immune cells may offer therapeutic strategies.
From chromatin binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of chromatin binding affect gene expression? | CRISPR knockout of the chromatin-binding domain |
| How does a point mutation alter binding affinity? | CRISPR point mutation (e.g., in CTCF zinc fingers) |
| Can a fusion protein track chromatin dynamics? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression drive oncogenesis? | Overexpression via lentiviral transduction |
| Which domains are essential for chromatin binding? | Domain-specific knockouts or deletions |
| How does a disease-associated mutation affect chromatin binding? | Knock-in of patient-derived mutation |
How to Study the chromatin binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide binding sites | Mapping CTCF, UHRF1, histone marks |
| ATAC-seq | Chromatin accessibility | Assessing impact of chromatin binders |
| Live-cell imaging | Dynamic binding kinetics | Cell cycle-dependent binding of TICRR |
| Proteomics (AP-MS) | Protein-protein interactions | Identifying chromatin-bound complexes |
| CRISPR screen | Genes affecting chromatin binding | Discovery of novel regulators |
| Single-molecule tracking | Binding dwell times | Quantifying transcription factor binding |
| FRAP | Binding turnover | Measuring exchange rates of chromatin proteins |
Chromatin immunoprecipitation (ChIP)
ChIP combined with sequencing (ChIP-seq) identifies genome-wide binding sites of chromatin-binding proteins. It is widely used to map CTCF, UHRF1, and histone modifications.
Live-cell imaging
Fluorescent tagging of chromatin-binding proteins allows real-time visualization of their dynamics. For example, GFP-tagged TICRR/TRESLIN reveals cell cycle-dependent binding patterns.
Proteomics and interactomics
Mass spectrometry-based approaches identify protein complexes associated with chromatin. This has revealed CAF-1 interaction with PCNA and condensin II activation by M18BP1.
CRISPR screens
Genome-wide CRISPR knockout screens can identify genes required for chromatin binding and downstream processes. Such screens are valuable for discovering novel regulators.
How CRISPR Can Be Used to Study GO:0003682 chromatin binding
Knockout
CRISPR knockout of genes encoding chromatin-binding proteins or their domains abolishes binding and reveals loss-of-function phenotypes. For example, knocking out CTCF disrupts chromatin loops and gene regulation.
Point Mutation
Introducing precise point mutations in chromatin-binding domains (e.g., DNA-contacting residues) allows dissection of binding specificity without affecting protein stability. This is useful for studying disease-associated mutations.
Knock-in
Knock-in of fluorescent tags or epitope tags at endogenous loci enables real-time tracking and biochemical isolation of chromatin-binding proteins. Tagged UHRF1 has been used to study its binding modes.
Overexpression
Overexpression of wild-type or mutant chromatin-binding proteins can reveal gain-of-function effects, such as oncogenic transformation or dominant-negative interference.
How EDITGENE Supports chromatin binding Research
Researchers studying chromatin binding-related genes often need to determine whether a candidate gene is causally involved in a specific process or disease. This requires precise genetic models that can isolate the contribution of chromatin-binding domains from other protein functions. EDITGENE provides a comprehensive suite of CRISPR services to generate such models efficiently.
Contact EDITGENE today to design your custom CRISPR model for chromatin binding research.
Frequently Asked Questions About chromatin binding
What is GO:0003682 chromatin binding?
GO:0003682 is a Gene Ontology molecular function term defined as binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
What genes are involved in chromatin binding?
Key genes include CTCF, UHRF1, CAF-1 subunits, EZHIP, TICRR/TRESLIN, MTBP, condensin II subunits, M18BP1, and myeloperoxidase, among others.
How is chromatin binding regulated?
It is regulated by post-translational modifications, cell cycle-dependent kinases, and enzymatic modification of chromatin itself.
What diseases are associated with defective chromatin binding?
Cancer, developmental disorders, and autoimmune conditions such as lupus have been linked to altered chromatin binding.
What methods are used to study chromatin binding?
Common methods include ChIP-seq, ATAC-seq, live-cell imaging, proteomics, and CRISPR screens.
Can CRISPR be used to study chromatin binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect chromatin binding mechanisms.
What is the role of CTCF in chromatin binding?
CTCF binds specific DNA sequences to organize chromatin loops and insulate gene expression.
How does UHRF1 bind chromatin?
UHRF1 uses conserved linker regions to recognize hemimethylated DNA and histone marks, enabling multiple binding modes.
What is the significance of condensin II chromatin binding?
Condensin II binds chromatin to compact chromosomes during mitosis, and its activation by M18BP1 is essential for genome stability.
How does myeloperoxidase interact with chromatin?
Myeloperoxidase modifies chromatin to transform it into neutrophil extracellular traps, a process important in innate immunity.
Conclusion
Chromatin binding (GO:0003682) is a cornerstone molecular function that underpins genome organization, gene regulation, and cell division. The diverse proteins that mediate this function are implicated in cancer, developmental disorders, and immune diseases. Advanced CRISPR models and bioinformatics tools are essential to unravel the precise mechanisms and therapeutic potential of chromatin-binding proteins. EDITGENE offers comprehensive services to support these research endeavors.
References
- 1. Zeng Y et al.. 2025. EZHIP restricts noncanonical PRC2 binding and regulates H3K27me3 intergenerational inheritance and reprogramming.. Cell Stem Cell 32(11):1741-1757.e5 PMID: 41118764
- 2. Portillo-Ledesma S et al.. 2024. Regulation of chromatin architecture by transcription factor binding.. Elife 12 PMID: 38241351
- 3. Burn GL et al.. 2025. Myeloperoxidase transforms chromatin into neutrophil extracellular traps.. Nature 647(8090):747-756 PMID: 40963017
- 4. Gopinathan Nair A et al.. 2022. Unorthodox PCNA Binding by Chromatin Assembly Factor 1.. Int J Mol Sci 23(19) PMID: 36232396
- 5. Tauber M et al.. 2015. Conserved linker regions and their regulation determine multiple chromatin-binding modes of UHRF1.. Nucleus 6(2):123-32 PMID: 25891992
- 6. Holwerda SJ et al.. 2013. CTCF: the protein, the binding partners, the binding sites and their chromatin loops.. Philos Trans R Soc Lond B Biol Sci 368(1620):20120369 PMID: 23650640
- 7. Noble TD et al.. 2025. Cell cycle-dependent TICRR/TRESLIN and MTBP chromatin binding mechanisms and patterns.. Genome Biol 26(1):194 PMID: 40624716
- 8. Borsellini A et al.. 2025. Condensin II activation by M18BP1.. Mol Cell 85(14):2688-2700.e11 PMID: 40614722
